Ge Healthcare Company Profile

✉ Email this page to a colleague

GE HEALTHCARE has fifty approved drugs.

There is one US patent protecting GE HEALTHCARE drugs.

There are twenty patent family members on GE HEALTHCARE drugs in twenty countries and one hundred and sixty-five supplementary protection certificates in eighteen countries.

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ge Healthcare	DICOPAC KIT	cyanocobalamin; cyanocobalamin co-57; cyanocobalamin co-58	N/A;N/A	017406-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Ge Healthcare	SODIUM IODIDE I 123	sodium iodide i-123	CAPSULE;ORAL	017630-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Ge Healthcare	HYPAQUE SODIUM 20%	diatrizoate sodium	SOLUTION;URETERAL	009561-002	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Ge Healthcare	TECHNETIUM TC 99M SULFUR COLLOID	technetium tc-99m sulfur colloid	SOLUTION;INJECTION, ORAL	017456-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Ge Healthcare	OMNIPAQUE 12	iohexol	SOLUTION;ORAL	018956-009	Apr 17, 2018		RX	Yes	Yes		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Ge Healthcare	OMNISCAN	gadodiamide	INJECTABLE;INJECTION	020123-001	Jan 8, 1993	5,560,903	⤷ Start Trial
Ge Healthcare	VISIPAQUE 320	iodixanol	INJECTABLE;INJECTION	020351-002	Mar 22, 1996	4,278,654	⤷ Start Trial
Ge Healthcare	ISOPAQUE 280	calcium; meglumine; metrizoic acid	INJECTABLE;INJECTION	017506-001	Approved Prior to Jan 1, 1982	3,476,802	⤷ Start Trial
Ge Healthcare	VIZAMYL	flutemetamol f-18	INJECTABLE;INTRAVENOUS	203137-001	Oct 25, 2013	8,236,282	⤷ Start Trial
Ge Healthcare	VISIPAQUE 270	iodixanol	INJECTABLE;INJECTION	020351-001	Mar 22, 1996	4,396,597	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Subscribe to access the full database, or Start Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
3347352	2290051-8	Sweden	⤷ Start Trial	PRODUCT NAME: LENACAPAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR LENACAPAVIR SODIUM; REG. NO/DATE: EU/1/22/1671 20220819
2182988	1590009-5	Sweden	⤷ Start Trial	PRODUCT NAME: FLUTEMETAMOL (18F); REG. NO/DATE: EU/1/14/941 20140826
0961612	CA 2009 00036	Denmark	⤷ Start Trial	PRODUCT NAME: PACLITAXELALBUMIN
1189916	2011C/004	Belgium	⤷ Start Trial	PRODUCT NAME: REGADENOSON; AUTHORISATION NUMBER AND DATE: EU/1/10/643/001 20100906
2182988	CR 2015 00008	Denmark	⤷ Start Trial	PRODUCT NAME: FLUTEMETAMOL (18F); REG. NO/DATE: EU/1/14/941 20140826
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.